⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15942919 | 0.77 | CSNK2A1 (0.30) | — | |
| SCHEMBL3380555 | 0.76 | — | — | |
| SCHEMBL14995255 | 0.73 | TAAR1 (0.42) | — | |
| SCHEMBL20738457 | 0.73 | SLC6A3 (0.34) | — | |
| SCHEMBL23770540 | 0.71 | — | — | |
| SCHEMBL10197110 | 0.71 | — | — | |
| SCHEMBL128816 | 0.71 | — | — | |
| SCHEMBL15481049 | 0.71 | — | — | |
| SCHEMBL13721451 | 0.71 | — | — | |
| Ammonia Solution, Strong SCHEMBL27906407 | 0.71 | SMN1; SMN2 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023086539-A2 | BCAT2 INHIBITORS | AGIOS PHARMACEUTICALS, INC. (US) | 2023-05-19 | — | — | WO | disclosed |
| EP-3811974-A1 | TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS | Infinity Pharmaceuticals, Inc. (US) | 2021-04-28 | — | — | EP | disclosed |
| CN-107382997-B | Process and intermediates for the preparation of pharmaceutical agents | 吉利德科学公司 | 2021-02-26 | — | — | CN | disclosed |
| CN-111217808-A | Process and intermediates for the preparation of pharmaceutical agents | 吉利德科学公司 | 2020-06-02 | — | — | CN | disclosed |
| EP-3613743-A1 | PROCESSES FOR THE PREPARATION OF 1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE DERIVATIVES | Intellikine, LLC (US) | 2020-02-26 | — | — | EP | disclosed |
| CN-104876888-B | It is used to prepare the method and intermediate of drug agents | 吉利德科学公司 | 2018-06-15 | — | — | CN | disclosed |
| CN-107382997-A | For preparing the method and intermediate of drug agents | 吉利德科学公司 | 2017-11-24 | — | — | CN | disclosed |
| US-20170183330-A1 | BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER | CAPELLA THERAPEUTICS, INC. (US) | 2017-06-29 | — | — | US | disclosed |
| US-9428473-B2 | Methods and intermediates for preparing pharmaceutical agents | GILEAD SCIENCES, INC. (US) | 2016-08-30 | — | — | US | disclosed |
| EP-3009434-A1 | METHOD OF PREPARING AN INHIBITOR OF CYTOCHROME P450 MONOOXYGENASE, AND INTERMEDIATES INVOLVED | GILEAD SCIENCES, INC. (US) | 2016-04-20 | — | — | EP | disclosed |
| US-20160002186-A1 | METHODS AND INTERMEDIATES FOR PREPARING PHARMACEUTICAL AGENTS | GILEAD SCIENCES, INC. | 2016-01-07 | — | — | US | disclosed |
| EP-2414325-B1 | METHOD OF PREPARING AN INHIBITOR OF CYTOCHROME P450 MONOOXYGENASE, AND INTERMEDIATES INVOLVED. | GILEAD SCIENCES INC (US) | 2015-08-26 | — | — | EP | disclosed |
| US-9115100-B2 | Methods and intermediates for preparing pharmaceutical agents | GILEAD SCIENCES, INC. (US) | 2015-08-25 | — | — | US | disclosed |
| US-20150005493-A1 | METHODS AND INTERMEDIATES FOR PREPARING PHARMACEUTICAL AGENTS | GILEAD SCIENCES, INC. | 2015-01-01 | — | — | US | disclosed |
| US-8853210-B2 | Methods and intermediates for preparing pharmaceutical agents | GILEAD SCIENCES, INC. (US) | 2014-10-07 | — | — | US | disclosed |
| US-20140088304-A1 | METHODS AND INTERMEDIATES FOR PREPARING PHARMACEUTICAL AGENTS | GILEAD SCIENCES, INC. (US) | 2014-03-27 | — | — | US | disclosed |
| US-8497396-B2 | Methods and intermediates for preparing pharmaceutical agents | GILEAD SCIENCES, INC. (US) | 2013-07-30 | — | — | US | disclosed |
| EP-2414325-A2 | METHOD OF PREPARING AN INHIBITOR OF CYTOCHROME P450 MONOOXYGENASE, AND INTERMEDIATES INVOLVED | Gilead Sciences, Inc. (US) | 2012-02-08 | — | — | EP | disclosed |
| WO-2010115000-A2 | METHODS AND INTERMEDIATES FOR PREPARING PHARMACEUTICAL AGENTS | GILEAD SCIENCES, INC. (US) | 2010-10-07 | — | — | WO | disclosed |
| US-20100256366-A1 | METHODS AND INTERMEDIATES FOR PREPARING PHARMACEUTICAL AGENTS | GILEAD SCIENCES, INC. | 2010-10-07 | — | — | US | disclosed |